GLP-1 Reduces appetite, slows gastric emptying GIP Enhances insulin, improves fat metabolism Glucagon Increases energy expenditure, burns fat Based on Phase 2 clinical trial data (published in NEJM, 2023), retatrutide's side effects are primarily gastrointestinal, similar to other GLP-1 agonists but with some differences due to the glucagon component
You may know people who have had great success using one of these drugs for weight loss, and you may think, if one weight loss drug is so beneficial, should I try both at the same time
Many of these chronic gut health conditions have a connection to autoimmune disease, and we take a direct approach to addressing the root cause rather than simply masking symptoms with medication
As we delve into this topic, we'll explore the intricate relationship between glutathione, weight management, and overall health
This imbalance in macrophage polarization underscores the inflammatory mechanisms driving hepatic metabolic dysfunction and highlights a potential therapeutic target for mitigating MASLD-associated insulin resistance (209)
[PMID: 4399934] PubMed record related to this compound for laboratory literature review